$1.72 Billion in Sales Expected for The Clorox Company (NYSE:CLX) This Quarter

Brokerages expect The Clorox Company (NYSE:CLX) to post sales of $1.72 billion for the current quarter, according to Zacks. Three analysts have issued estimates for The Clorox’s earnings. The lowest sales estimate is $1.71 billion and the highest is $1.74 billion. The Clorox posted sales of $1.45 billion in the same quarter last year, which would indicate a positive year-over-year growth rate of 18.6%. The company is scheduled to issue its next earnings report on Tuesday, February 2nd.

According to Zacks, analysts expect that The Clorox will report full-year sales of $7.33 billion for the current financial year, with estimates ranging from $7.27 billion to $7.39 billion. For the next fiscal year, analysts expect that the firm will post sales of $7.43 billion, with estimates ranging from $7.09 billion to $7.64 billion. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that cover The Clorox.

The Clorox (NYSE:CLX) last issued its quarterly earnings results on Saturday, November 7th. The company reported $3.22 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.32 by $0.90. The Clorox had a return on equity of 132.72% and a net margin of 16.14%. The firm had revenue of $1.92 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the previous year, the company posted $1.59 earnings per share. The company’s revenue was up 27.2% compared to the same quarter last year.

Several equities research analysts recently weighed in on CLX shares. JPMorgan Chase & Co. cut The Clorox from an “overweight” rating to a “neutral” rating and set a $235.00 target price for the company. in a report on Friday, October 16th. They noted that the move was a valuation call. DA Davidson increased their target price on The Clorox from $263.00 to $268.00 and gave the company a “buy” rating in a report on Tuesday, November 3rd. Wells Fargo & Company started coverage on The Clorox in a report on Monday, December 7th. They set an “overweight” rating and a $250.00 target price for the company. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell upgraded The Clorox from a “neutral” rating to a “buy” rating and increased their target price for the company from $238.00 to $249.00 in a report on Sunday, December 13th. Finally, ValuEngine cut The Clorox from a “hold” rating to a “sell” rating in a report on Tuesday, November 10th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have assigned a buy rating to the stock. The Clorox presently has a consensus rating of “Hold” and an average target price of $220.53.

Shares of CLX stock opened at $201.92 on Friday. The stock has a market capitalization of $25.45 billion, a PE ratio of 22.49, a P/E/G ratio of 4.32 and a beta of 0.21. The Clorox has a 1-year low of $150.95 and a 1-year high of $239.87. The business has a 50-day moving average of $202.87 and a 200 day moving average of $214.77. The company has a debt-to-equity ratio of 2.12, a current ratio of 1.41 and a quick ratio of 1.06.

The company also recently announced a quarterly dividend, which will be paid on Friday, February 12th. Stockholders of record on Wednesday, January 27th will be paid a $1.11 dividend. This represents a $4.44 dividend on an annualized basis and a dividend yield of 2.20%. The ex-dividend date is Tuesday, January 26th. The Clorox’s payout ratio is presently 60.33%.

In related news, EVP Laura Stein sold 19,430 shares of the firm’s stock in a transaction that occurred on Thursday, November 5th. The stock was sold at an average price of $215.46, for a total transaction of $4,186,387.80. Following the completion of the transaction, the executive vice president now owns 59,755 shares of the company’s stock, valued at approximately $12,874,812.30. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Diego J. Barral sold 9,916 shares of the firm’s stock in a transaction that occurred on Wednesday, December 9th. The shares were sold at an average price of $200.19, for a total value of $1,985,084.04. Following the transaction, the senior vice president now directly owns 9,651 shares of the company’s stock, valued at approximately $1,932,033.69. The disclosure for this sale can be found here. In the last 90 days, insiders sold 473,319 shares of company stock valued at $95,666,491. 1.09% of the stock is currently owned by company insiders.

A number of hedge funds have recently bought and sold shares of the stock. Wetherby Asset Management Inc. increased its position in The Clorox by 1.5% during the 3rd quarter. Wetherby Asset Management Inc. now owns 4,653 shares of the company’s stock valued at $978,000 after buying an additional 70 shares in the last quarter. Mercer Global Advisors Inc. ADV increased its holdings in shares of The Clorox by 253.9% in the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 25,614 shares of the company’s stock worth $5,553,000 after purchasing an additional 18,377 shares in the last quarter. Sei Investments Co. increased its holdings in shares of The Clorox by 25.3% in the 3rd quarter. Sei Investments Co. now owns 75,293 shares of the company’s stock worth $15,790,000 after purchasing an additional 15,223 shares in the last quarter. Platform Technology Partners bought a new stake in shares of The Clorox in the 3rd quarter worth $748,000. Finally, Kathmere Capital Management LLC bought a new stake in shares of The Clorox in the 3rd quarter worth $84,000. 75.81% of the stock is owned by institutional investors.

About The Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands.

Further Reading: What is a Stop Order?

Get a free copy of the Zacks research report on The Clorox (CLX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.